Replies to post #3600 on Insmed Inc (INSM)

[yourgoodo]

I think the volume over last week was great for INSM, but attributing it to funds/institutions/big-boys is unlikely. Remember, the 15mil shares traded were trading at a measly ~$1.50. It would only take 150 separate individuals, investing $100k to get that volume (only 1500 investing $10k). These numbers just demonstrate that it doesn't take much to reach volume of 15mil for a stock priced at ~$1.50.

I think INSM saw a lot of smart traders, not necessarily smart investors, investing in a volatile stock.

I too believe in Insmed as a long-term investment, although the point has been made many times here: we are not investing in a trial outcome, rather the investment is in a biopharmaceutical company (that just happens to be in litigation).

We, as Insmed, will move beyond this litigation. . .